WallStreetZenWallStreetZen

NASDAQ: PTPI
Petros Pharmaceuticals Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

PTPI past revenue growth

How has PTPI's revenue growth performed historically?
Company
-2.83%
Industry
9.98%
Market
17.61%
PTPI's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
PTPI's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

PTPI earnings and revenue history

Current Revenue
$5.8M
Current Earnings
-$13.8M
Current Profit Margin
-237.3%

PTPI Return on Equity

Current Company
-116.6%
Current Industry
15.4%
Current Market
188%
PTPI's Return on Equity (-116.6%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when PTPI announces earnings.

PTPI Return on Assets

Current Company
-41.9%
Current Industry
3.4%
PTPI is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

PTPI Return on Capital Employed

Current Company
-33.13%
Current Industry
5.1%
PTPI has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PTPI vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
PTPI$5.82M-$4.21M-$13.81M-21.81%N/A
CPHI$7.01M$8.44k-$3.08M-10.68%N/A
EVOK$5.18M-$7.16M-$7.79M+607.36%N/A
SBFM$24.09M-$3.82M-$4.51M+481.16%N/A
YCBD$23.45M-$17.13M-$23.98M+150.64%N/A
View Top Pharmaceutical Stocks

Petros Pharmaceuticals Earnings & Revenue FAQ

What were PTPI's earnings last quarter?

Petros Pharmaceuticals (NASDAQ: PTPI) reported Q4 2023 earnings per share (EPS) of -$2.17, up 6.9% year over year. Total Petros Pharmaceuticals earnings for the quarter were -$4.99 million. In the same quarter last year, Petros Pharmaceuticals's earnings per share (EPS) was -$2.03.

If you're new to stock investing, here's how to buy Petros Pharmaceuticals stock.

What was PTPI's earnings growth in the past year?

As of Q2 2024, Petros Pharmaceuticals's earnings has grown year over year. Petros Pharmaceuticals's earnings in the past year totalled -$13.81 million.

What was PTPI's revenue last quarter?

Petros Pharmaceuticals (NASDAQ: PTPI) reported Q4 2023 revenue of -$364.25 thousand up 145.64% year over year. In the same quarter last year, Petros Pharmaceuticals's revenue was $798.10 thousand.

What was PTPI's revenue growth in the past year?

As of Q2 2024, Petros Pharmaceuticals's revenue has grown -2.83% year over year. This is 12.81 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 9.98%. Petros Pharmaceuticals's revenue in the past year totalled $5.82 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.